Drugs

Big Pharma's Patent Cliff


Drugs going off-patent in 2014 contribute just under $50 billion in pharmaceutical industry revenue. Not all products losing protection face imminent competition from generics; biological products and drugs delivered by devices are best poised to extend their money-spinning streak.


The Good Business Issue
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus